Ryan Gerbrandt - May 5, 2021 Form 4/A - Amendment Insider Report for Anterix Inc. (ATEX)

Role
Chief Operating Officer
Signature
/s/ Gena Ashe, attorney-in-fact
Stock symbol
ATEX
Transactions as of
May 5, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/10/2021, 06:33 PM
Date Of Original Report
May 6, 2021
Next filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATEX Common Stock Award $0 +26.1K +138.8% $0.00 44.9K May 5, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 15, 2022, with the remaining RSUs vesting in 3 equal annual installments thereafter. The prior Form 4 incorrectly reported that 25% of the RSUs vest and become exercisable on May 5, 2022, with the remaining RSUs vesting in 3 equal annual installments thereafter.